332 related articles for article (PubMed ID: 17496433)
1. Reactivity of synthetic SAG1 (p30) peptide sequences with RH, S273 and Beverley strain-induced anti-Toxoplasma gondii antibodies.
Kato M; Claveria FG; Maki Y; Sanda K; Tanaka T; Omata Y; Nagasawa H; Suzuki N
Pathobiology; 2007; 74(1):50-6. PubMed ID: 17496433
[TBL] [Abstract][Full Text] [Related]
2. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
3. SAG1 is a host-targeted antigen for protection against toxoplasma gondii infection.
Seng S; Makala LH; Yokoyama M; Lim C; Choi YH; Suzuki N; Toyoda Y; Nagasawa H
Pathobiology; 2004; 71(3):144-51. PubMed ID: 15051927
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model.
Siachoque H; Guzman F; Burgos J; Patarroyo ME; Gomez Marin JE
Exp Parasitol; 2006 Sep; 114(1):62-5. PubMed ID: 16545806
[TBL] [Abstract][Full Text] [Related]
5. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
Li WS; Xie ZX; Chen QX; Chen S; Zhang LF
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):359-63. PubMed ID: 21351549
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii: P30 peptides recognition pattern in human toxoplasmosis.
Cardona N; de-la-Torre A; Siachoque H; Patarroyo MA; Gomez-Marin JE
Exp Parasitol; 2009 Oct; 123(2):199-202. PubMed ID: 19567250
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response.
Graille M; Stura EA; Bossus M; Muller BH; Letourneur O; Battail-Poirot N; Sibaï G; Gauthier M; Rolland D; Le Du MH; Ducancel F
J Mol Biol; 2005 Nov; 354(2):447-58. PubMed ID: 16242717
[TBL] [Abstract][Full Text] [Related]
8. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasma gondii: enzyme-linked immunosorbent assay using different fragments of recombinant microneme protein 1 (MIC1) for detection of immunoglobulin G antibodies.
Holec L; Gasior A; Brillowska-Dabrowska A; Kur J
Exp Parasitol; 2008 May; 119(1):1-6. PubMed ID: 18207143
[TBL] [Abstract][Full Text] [Related]
10. Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris.
Lau YL; Fong MY
Exp Parasitol; 2008 Jul; 119(3):373-8. PubMed ID: 18457835
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
Qu D; Wang S; Cai W; Du A
Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
[TBL] [Abstract][Full Text] [Related]
12. Use of SAG2A recombinant Toxoplasma gondii surface antigen as a diagnostic marker for human acute toxoplasmosis: analysis of titers and avidity of IgG and IgG1 antibodies.
Béla SR; Oliveira Silva DA; Cunha-Júnior JP; Pirovani CP; Chaves-Borges FA; Reis de Carvalho F; Carrijo de Oliveira T; Mineo JR
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):245-54. PubMed ID: 18703303
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
[TBL] [Abstract][Full Text] [Related]
14. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the antigenic value of recombinant Toxoplasma gondii HSP20 to detect specific immunoglobulin G antibodies in Toxoplasma infected humans.
Cóceres VM; Becher ML; De Napoli MG; Corvi MM; Clemente M; Angel SO
Exp Parasitol; 2010 Oct; 126(2):263-6. PubMed ID: 20433835
[TBL] [Abstract][Full Text] [Related]
16. Toxoplasma gondii antigens GRA1 (p24) and SAG1 (p30): a comparison of their stimulatory influence on T-cell activation and cytokine expression in in vitro cultures.
Kato M; Claveria FG; Maki Y; Tanaka T; Suzuki N; Nagasawa H
Pathobiology; 2005; 72(3):160-4. PubMed ID: 15860934
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice.
Chen G; Chen H; Guo H; Zheng H
Chin Med J (Engl); 2002 Oct; 115(10):1448-52. PubMed ID: 12490084
[TBL] [Abstract][Full Text] [Related]
19. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen.
Darcy F; Maes P; Gras-Masse H; Auriault C; Bossus M; Deslee D; Godard I; Cesbron MF; Tartar A; Capron A
J Immunol; 1992 Dec; 149(11):3636-41. PubMed ID: 1431132
[TBL] [Abstract][Full Text] [Related]
20. Peptide-Based Monoclonal Antibody Production Against SAG1 (P30) Protein of
Naghi Vishteh M; Javadi Mamaghani A; Rashidi S; Seyyed Tabaei SJ; Jeddi-Tehrani M
Monoclon Antib Immunodiagn Immunother; 2020 Apr; 39(2):51-56. PubMed ID: 32216700
[No Abstract] [Full Text] [Related]
[Next] [New Search]
